METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER
FIELD: medicine, oncology. ^ SUBSTANCE: one should carry out surgical interference , distance gamma-therapy and hormonotherapy with aromatase inhibitors. Moreover, after surgical interference it is important to determine the level of aromatase in remote tumor, at its value being 7fM androstenedione/...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BOCHKAREVA NATAL'JA VALER'EVNA KOLOMIETS LARISA ALEKSANDROVNA MUNTJAN ALISA BORISOVNA KONDAKOVA IRINA VIKTOROVNA |
| description | FIELD: medicine, oncology. ^ SUBSTANCE: one should carry out surgical interference , distance gamma-therapy and hormonotherapy with aromatase inhibitors. Moreover, after surgical interference it is important to determine the level of aromatase in remote tumor, at its value being 7fM androstenedione/mg protein/h and more, despite the receptor status one should prescribe hormonotherapy with aromatase inhibitor - anastrosol - at the dosage of 1 mg/d once for 6 mo running on finishing distance gamma-therapy. Such a complex therapy due to taking into account the threshold value of aromatase level in tumor enables to decrease the frequency of local relapses considerably during the first 2 yr of life after therapy conducted, in case of minimal quantity of therapeutic complications. ^ EFFECT: higher efficiency of therapy. ^ 1 ex |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2297798C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2297798C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2297798C13</originalsourceid><addsrcrecordid>eNrjZHDzdQ3x8HdRcPMPUnD29w3wcY1QCAlydQzxdfULUfB3UwhyDXZ1DnF08nEFqfENBom5-rn4A_UFeTr6KDg7-jm7BvEwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkvigUCMjS3NzSwtnQ2MilAAAVRksFA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER</title><source>esp@cenet</source><creator>BOCHKAREVA NATAL'JA VALER'EVNA ; KOLOMIETS LARISA ALEKSANDROVNA ; MUNTJAN ALISA BORISOVNA ; KONDAKOVA IRINA VIKTOROVNA</creator><creatorcontrib>BOCHKAREVA NATAL'JA VALER'EVNA ; KOLOMIETS LARISA ALEKSANDROVNA ; MUNTJAN ALISA BORISOVNA ; KONDAKOVA IRINA VIKTOROVNA</creatorcontrib><description>FIELD: medicine, oncology. ^ SUBSTANCE: one should carry out surgical interference , distance gamma-therapy and hormonotherapy with aromatase inhibitors. Moreover, after surgical interference it is important to determine the level of aromatase in remote tumor, at its value being 7fM androstenedione/mg protein/h and more, despite the receptor status one should prescribe hormonotherapy with aromatase inhibitor - anastrosol - at the dosage of 1 mg/d once for 6 mo running on finishing distance gamma-therapy. Such a complex therapy due to taking into account the threshold value of aromatase level in tumor enables to decrease the frequency of local relapses considerably during the first 2 yr of life after therapy conducted, in case of minimal quantity of therapeutic complications. ^ EFFECT: higher efficiency of therapy. ^ 1 ex</description><language>eng ; rus</language><subject>DIAGNOSIS ; ELECTROTHERAPY ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MAGNETOTHERAPY ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; RADIATION THERAPY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SURGERY ; TESTING ; ULTRASOUND THERAPY</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070427&DB=EPODOC&CC=RU&NR=2297798C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070427&DB=EPODOC&CC=RU&NR=2297798C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BOCHKAREVA NATAL'JA VALER'EVNA</creatorcontrib><creatorcontrib>KOLOMIETS LARISA ALEKSANDROVNA</creatorcontrib><creatorcontrib>MUNTJAN ALISA BORISOVNA</creatorcontrib><creatorcontrib>KONDAKOVA IRINA VIKTOROVNA</creatorcontrib><title>METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER</title><description>FIELD: medicine, oncology. ^ SUBSTANCE: one should carry out surgical interference , distance gamma-therapy and hormonotherapy with aromatase inhibitors. Moreover, after surgical interference it is important to determine the level of aromatase in remote tumor, at its value being 7fM androstenedione/mg protein/h and more, despite the receptor status one should prescribe hormonotherapy with aromatase inhibitor - anastrosol - at the dosage of 1 mg/d once for 6 mo running on finishing distance gamma-therapy. Such a complex therapy due to taking into account the threshold value of aromatase level in tumor enables to decrease the frequency of local relapses considerably during the first 2 yr of life after therapy conducted, in case of minimal quantity of therapeutic complications. ^ EFFECT: higher efficiency of therapy. ^ 1 ex</description><subject>DIAGNOSIS</subject><subject>ELECTROTHERAPY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MAGNETOTHERAPY</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>RADIATION THERAPY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SURGERY</subject><subject>TESTING</subject><subject>ULTRASOUND THERAPY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDzdQ3x8HdRcPMPUnD29w3wcY1QCAlydQzxdfULUfB3UwhyDXZ1DnF08nEFqfENBom5-rn4A_UFeTr6KDg7-jm7BvEwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkvigUCMjS3NzSwtnQ2MilAAAVRksFA</recordid><startdate>20070427</startdate><enddate>20070427</enddate><creator>BOCHKAREVA NATAL'JA VALER'EVNA</creator><creator>KOLOMIETS LARISA ALEKSANDROVNA</creator><creator>MUNTJAN ALISA BORISOVNA</creator><creator>KONDAKOVA IRINA VIKTOROVNA</creator><scope>EVB</scope></search><sort><creationdate>20070427</creationdate><title>METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER</title><author>BOCHKAREVA NATAL'JA VALER'EVNA ; KOLOMIETS LARISA ALEKSANDROVNA ; MUNTJAN ALISA BORISOVNA ; KONDAKOVA IRINA VIKTOROVNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2297798C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2007</creationdate><topic>DIAGNOSIS</topic><topic>ELECTROTHERAPY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MAGNETOTHERAPY</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>RADIATION THERAPY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SURGERY</topic><topic>TESTING</topic><topic>ULTRASOUND THERAPY</topic><toplevel>online_resources</toplevel><creatorcontrib>BOCHKAREVA NATAL'JA VALER'EVNA</creatorcontrib><creatorcontrib>KOLOMIETS LARISA ALEKSANDROVNA</creatorcontrib><creatorcontrib>MUNTJAN ALISA BORISOVNA</creatorcontrib><creatorcontrib>KONDAKOVA IRINA VIKTOROVNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BOCHKAREVA NATAL'JA VALER'EVNA</au><au>KOLOMIETS LARISA ALEKSANDROVNA</au><au>MUNTJAN ALISA BORISOVNA</au><au>KONDAKOVA IRINA VIKTOROVNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER</title><date>2007-04-27</date><risdate>2007</risdate><abstract>FIELD: medicine, oncology. ^ SUBSTANCE: one should carry out surgical interference , distance gamma-therapy and hormonotherapy with aromatase inhibitors. Moreover, after surgical interference it is important to determine the level of aromatase in remote tumor, at its value being 7fM androstenedione/mg protein/h and more, despite the receptor status one should prescribe hormonotherapy with aromatase inhibitor - anastrosol - at the dosage of 1 mg/d once for 6 mo running on finishing distance gamma-therapy. Such a complex therapy due to taking into account the threshold value of aromatase level in tumor enables to decrease the frequency of local relapses considerably during the first 2 yr of life after therapy conducted, in case of minimal quantity of therapeutic complications. ^ EFFECT: higher efficiency of therapy. ^ 1 ex</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2297798C1 |
| source | esp@cenet |
| subjects | DIAGNOSIS ELECTROTHERAPY HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MAGNETOTHERAPY MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SURGERY TESTING ULTRASOUND THERAPY |
| title | METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T01%3A19%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BOCHKAREVA%20NATAL'JA%20VALER'EVNA&rft.date=2007-04-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2297798C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |